ESMO 2019: Industry Participation

ESMO 2019, the world's premier congress in medical oncology will be taking place in Barcelona from the 27 September - 1 October 2019. 

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.

This is the ultimate goal of ESMO 2019 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO 2019 Congress

  • 27940 participants, 137 countries
  • 7366 sqm exhibition space, 195 exhibitors
  • 580 invited speakers
  • 195 sessions ESMO, 15 sessions EONS
  • 3352 submitted abstracts

How can I participate in 2019? 

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress. 

Contact the  ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO 2019 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of April 2019).

Companies
  • 3D Tech Omega Zeta SL
  • 3DforScience - Visuals for Bio & Health
  • 10x Genomics
  • Abbvie
  • Accord Healthcare
  • Advanced Accelerator Applications, a Novartis company
  • Agendia
  • Almac Group
  • Amgen (Europe) GmbH
  • Amoy Diagnostics Co., Ltd
  • Apogenix AG
  • Aptitude Health
  • Aptus Health
  • Astellas Pharma Europe Ltd.
  • AstraZeneca
  • Baxter Healthcare SA
  • Bayer
  • BeiGene, Ltd.
  • Biocartis
  • Biotype Diagnostic GmbH
  • BMJ
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Calithera Biosciences
  • Cancer Drug Interactions
  • Caris Life Sciences
  • Catalysis S.L.
  • CeGaT
  • Celgene
  • Celltrion Healthcare Co., Ltd.
  • Clinical Research Malaysia (CRM)
  • Clovis Oncology
  • Covance, Inc.
  • Daiichi Sankyo
  • ECS Progastrin SA
  • Eisai Europe Ltd
  • Elsevier B.V.
  • EntroGen
  • Europital
  • EUSA Pharma (UK) Ltd
  • Exelixis
  • F.Hoffmann-La Roche AG
  • Ferring International Center SA
  • Fresenius Kabi
  • Frontiers
  • Genmab
  • Genomic Health International Sarl
  • GSK
  • Guardant Health
  • HalioDx
  • Helsinn Healthcare
  • HTG Molecular Diagnostics
  • IBM Watson Health
  • Illumina
  • Incyte Biosciences International Sarl
  • Iovance Biotherapeutics
  • Ipsen
  • IQVIA Biotech
  • ITM Isotopen Technologien Muenchen AG
  • JAMA
  • Janssen Oncology
  • Kaiku Health
  • Karger Publishers
  • Konect
  • LeCancer.fr
  • Life Technologies, Ltd.
  • Lilly
  • Linical
  • Loxo Oncology, Inc.
  • medac GmbH
  • Median Technologies
  • Medscape Oncology
  • Menarini Silicon Biosystems
  • Merck
  • Molecular Health GmbH
  • MSD
  • Myriad Genetics
  • NanoString Technologies
  • National Comprehensive Cancer Network (NCCN)
  • NEJM Group
  • NeoGenomics Laboratories
  • Novartis Oncology
  • Nutricia Oncology
  • OncLive
  • OncoDNA S.A.
  • Oncompass Medicine
  • OSE Immunutherapeutics
  • Oxford University Press
  • Personal Genome Diagnostics
  • Pfizer Oncology
  • Pharma Mar
  • Pharmadab d.o.o.
  • Philips Molecular Pathway Dx
  • Pierre Fabre Oncology
  • Pivotal
  • PlexBio Co., Ltd.
  • PPD
  • Precision for Medicine, Oncology and Rare Disease
  • prIME Oncology
  • Rakuten Aspyrian
  • Samsung Bioepis Co., Ltd.
  • Sanofi Genzyme
  • Seattle Genetics
  • Servier
  • Sophia Genetics
  • Sotio a.s.
  • Springer Healthcare
  • Stemline Therapeutics, Inc.
  • Sysmex Inostics GmbH
  • Takeda Oncology
  • Taylor & Francis
  • Tesaro
  • The Video Journal of Oncology
  • Thermo Fisher Scientific
  • Translational Research in Oncology (TRIO)
  • Varian Medical Systems
  • WeHealth by Servier
  • Wisepress Ltd